Eisai Asks 3rd Circ. To Rehear Lovenox Antitrust Suit
Pharmaceutical company Eisai asked the full Third Circuit on Wednesday to revisit the company's bid to revive an antitrust suit against Sanofi, arguing that the panel set a harmful precedent for...To view the full article, register now.
Already a subscriber? Click here to view full article